Skip to main content
. 2002 Jan 21;2002(1):CD003530. doi: 10.1002/14651858.CD003530

1.19. Analysis.

1.19

Comparison 1 BDP v BUD crossover design studies, no OCS: all doses, Outcome 19 Symptoms (daytime breathlessness, morning breathlessness, daily symptom scores combined).